Hence, the ATP synthase/IF1 axis offers a valuable therapeutic target to treat cognitive deficits associated with neurodegenerative and age-associated conditions (Goldberg et al., 2018). This evidence concerns the gene ATP5IF1 and Cognitive impairment.